-
公开(公告)号:BRPI1010933A2
公开(公告)日:2016-04-05
申请号:BRPI1010933
申请日:2010-05-19
Applicant: BASF SE
Inventor: MRZENA FRANK , COX GERHARD , KINDER HANS-JUERGEN , SCHOENHERR MICHAEL , SCHMIDT THOMAS , HUETT VOLKER
IPC: C07C227/42 , C07C229/24
-
公开(公告)号:DK2432759T3
公开(公告)日:2013-03-04
申请号:DK10723028
申请日:2010-05-19
Applicant: BASF SE
Inventor: MRZENA FRANK , KINDER HANS-JUERGEN , SCHOENHERR MICHAEL , COX GERHARD , SCHMIDT THOMAS , HUETT VOLKER
IPC: C07C227/42 , C07C229/24
-
公开(公告)号:BRPI0618033A2
公开(公告)日:2013-01-08
申请号:BRPI0618033
申请日:2006-10-27
Applicant: BASF SE
Inventor: KOBER REINER , STADLER REINHOLD , SCHNEIDER KARL-HEINRICH , SCHOENHERR MICHAEL
-
公开(公告)号:SG175760A1
公开(公告)日:2011-12-29
申请号:SG2011077179
申请日:2010-05-19
Applicant: BASF SE
Inventor: MRZENA FRANK , KINDER HANS-JUERGEN , SCHOENHERR MICHAEL , COX GERHARD , SCHMIDT THOMAS , HUETT VOLKER
Abstract: AbstractPROCESS FOR PREPARING A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE N,N-DIACETIC ACID AND/OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N-DIACETIC ACID AND METHYLGLYCINE-N,N-DIACETIC ACID TRISODIUM SALT POWDER5 A process is proposed for the preparation of a powder comprising one or more derivatives of glycine-N,N-diacetic acid and/or one or more derivatives of glutamine N,N-diacetic acid with a degree of crystallinity of..? 30%,starting from an aqueous solution comprising the one or more derivatives of glycine N,N-diacetic acid and/or the one or more derivatives of glutamine-N,N-diacetic acid in a10 concentration range from 20 to 60% by weight, based on the total weight of the aqueous solution, wherethe aqueous solution is concentrated in a first process step in an evaporator with rotating internals, which are arranged at a distance relative to the inside wall of the evaporator of 5 1% of the diameter of the evaporator, to give a crystal slurry with a15 solids concentration in the range from 60 to 85% by weight, based on the total weight of the crystal slurry, and wherein a second process step the crystal slurry is left to ripen in a paste bunker and then in a thin-film contact dryer, and where the residence time in the paste bunker and in the thin-film contact dryer is in total 15 minutes.(Figure 5)
-
公开(公告)号:BRPI0620185A2
公开(公告)日:2013-01-15
申请号:BRPI0620185
申请日:2006-12-11
Applicant: BASF SE
Inventor: KOLTER KARL , WICHTNER MARCUS , SCHOENHERR MICHAEL , MITTWOLLEN JAN-PETER
Abstract: A pharmaceutical formulation in the form of agglomerates comprising a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of crosslinked polyvinylpyrrolidone, c) 1-15% by weight of water-insoluble, film-forming polymers, d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients, the sum of the components a) to e) being 100% by weight.
-
公开(公告)号:SG178076A1
公开(公告)日:2012-03-29
申请号:SG2012004552
申请日:2010-05-19
Applicant: BASF SE
Inventor: MRZENA FRANK , SCHOENHERR MICHAEL , HEINZ ROBERT , HEIDENFELDER THOMAS
Abstract: AbstractProcess for the preparation of a spray powder comprising one or more glycine-N,N- diacetic acid derivatives and use of the spray powder for producing compression agglomeratesA process is prepared for the preparation of a spray powder comprising one or moreglycine-N,N-diacetic acid derivates of the general formula (I)MOOC-CHR-N(CH2COOM)x (I), with the meaning R is C[err]-alkyl and M is alkali metal, starting from an aqueous solution comprising the one or more glycine-N,N-diacetic acid derivatives which is spray-dried with the introduction of air, wherein -the aqueous solution comprises the one or more glycine-N,N-diacetic acid derivatives in a fraction of [err] 84% by weight based on the total weight of the dry mass and - the spray-drying takes places in a drying apparatus to which the aqueous solution and the air are passed concurrently, with a temperature gradient between the aqueous solution and the air in the range from 70 to 350[err]C, and - in the drying apparatus, the aqueous solution is atomized into fine liquid droplets by feeding it onto one or more disks which relate at a peripheral speed of [err] 100m/s or by compressing it by means of a pump to a pressure of [err] 20 bar absolute and, at this pressure, feeding it into the drying apparatus via one or more jets. No suitable figure
-
公开(公告)号:AU2010251173A1
公开(公告)日:2012-01-19
申请号:AU2010251173
申请日:2010-05-19
Applicant: BASF SE
Inventor: MRZENA FRANK , SCHOENHERR MICHAEL , HEINZ ROBERT , HEIDENFELDER THOMAS
Abstract: The invention relates to a method for producing a spray powder containing one or more glycine-N,N-diacetic acid derivatives of the general formula (I) MOOC-CHR-N(CHCOOM) (I), R standing for C alkyl and M standing for alkali metal, starting from an aqueous solution containing the one or more glycine-N,N-diacetic acid derivatives, which is spray-dried by adding air, characterized in that - the aqueous solution contains the one or more glycine-N,N-diacetic acid derivatives at a fraction of ≥ 84 wt.% relative to the total weight of the dry mass, and that - the spray drying occurs in a drying apparatus, to which the aqueous solution and the air are fed in parallel flow, with a temperature gradient between the aqueous solution and the air in the range of 70 to 350 °C, and that - in the drying apparatus, the aqueous solution is atomized into fine liquid droplets by being guided onto one or more disks, which rotate at a circumferential speed of ≥ 100 m/s, or by being compressed by means of a pump to a pressure of ≥ 20 bar absolute and introduced into the drying apparatus at this pressure by means of one or more nozzles.
-
公开(公告)号:PL1765967T3
公开(公告)日:2018-09-28
申请号:PL05756996
申请日:2005-07-01
Applicant: BASF SE
Inventor: WITTELER HELMUT , SCHOENHERR MICHAEL , HARTMANN MARKUS
-
-
公开(公告)号:BRPI0812064A2
公开(公告)日:2014-11-25
申请号:BRPI0812064
申请日:2008-06-03
Applicant: BASF SE
Inventor: KOLTER KARL , SCHOENHERR MICHAEL , GEBERT SILKE , MEYER-BOEHM KATHRIN , MASCHKE ANGELIKA
Abstract: Pharmaceutical formulation in the form of agglomerates comprising A) an excipient content composed of a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of a disintegrant, c) 1-15% by weight of water-insoluble, film-forming polymers d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients the total of the components a) to e) being 100% by weight, and B) at least one active ingredient.
-
-
-
-
-
-
-
-
-